Balchem Corporation Logo

Balchem Corporation

BCPC

(2.2)
Stock Price

178,28 USD

16.02% ROA

10.7% ROE

44.06x PER

Market Cap.

4.569.369.898,00 USD

37.5% DER

0.56% Yield

11.77% NPM

Balchem Corporation Stock Analysis

Balchem Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Balchem Corporation Fundamental Stock Analysis
# Analysis Rating
1 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

2 DER

The stock has a low debt to equity ratio (37%), which means it has a small amount of debt compared to the ownership it holds

3 Net Profit Growth

This company has consistently achieved strong net profit growth over the past five years, demonstrating a solid financial performance and making it an appealing investment option.

4 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (1.210), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

5 ROE

The stock's ROE falls within an average range (10.48%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

6 Revenue Growth

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 PBV

The stock's elevated P/BV ratio (3.84x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

Balchem Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Balchem Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

Balchem Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Balchem Corporation Revenue
Year Revenue Growth
1985 5.200.000
1986 5.800.000 10.34%
1987 6.800.000 14.71%
1988 8.400.000 19.05%
1989 9.600.000 12.5%
1990 10.800.000 11.11%
1991 12.700.000 14.96%
1992 12.700.000 0%
1993 14.700.000 13.61%
1994 18.900.000 22.22%
1995 25.000.000 24.4%
1996 26.400.000 5.3%
1997 28.600.000 7.69%
1998 28.700.000 0.35%
1999 29.700.000 3.37%
2000 33.198.000 10.54%
2001 46.142.000 28.05%
2002 60.197.000 23.35%
2003 61.875.000 2.71%
2004 67.406.000 8.21%
2005 839.095.000 91.97%
2006 100.905.000 -731.57%
2007 176.201.000 42.73%
2008 232.050.000 24.07%
2009 219.438.000 -5.75%
2010 255.071.000 13.97%
2011 291.867.000 12.61%
2012 310.393.000 5.97%
2013 337.173.000 7.94%
2014 541.383.000 37.72%
2015 552.492.000 2.01%
2016 553.204.000 0.13%
2017 594.790.000 6.99%
2018 643.679.000 7.6%
2019 643.705.000 0%
2020 703.644.000 8.52%
2021 799.023.000 11.94%
2022 942.358.000 15.21%
2023 919.792.000 -2.45%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Balchem Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 600.000 100%
1995 800.000 25%
1996 800.000 0%
1997 1.100.000 27.27%
1998 1.000.000 -10%
1999 1.300.000 23.08%
2000 1.069.000 -21.61%
2001 1.631.000 34.46%
2002 1.907.000 14.47%
2003 2.083.000 8.45%
2004 1.752.000 -18.89%
2005 2.053.000 14.66%
2006 2.019.000 -1.68%
2007 2.514.000 19.69%
2008 2.877.000 12.62%
2009 3.298.000 12.77%
2010 3.190.000 -3.39%
2011 2.890.000 -10.38%
2012 3.422.000 15.55%
2013 3.622.000 5.52%
2014 4.810.000 24.7%
2015 5.990.000 19.7%
2016 7.325.000 18.23%
2017 9.305.000 21.28%
2018 11.592.000 19.73%
2019 11.377.000 -1.89%
2020 10.332.000 -10.11%
2021 13.524.000 23.6%
2022 12.191.000 -10.93%
2023 15.472.000 21.21%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Balchem Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1985 1.900.000
1986 2.100.000 9.52%
1987 2.500.000 16%
1988 2.900.000 13.79%
1989 3.100.000 6.45%
1990 3.600.000 13.89%
1991 4.300.000 16.28%
1992 4.900.000 12.24%
1993 5.200.000 5.77%
1994 5.900.000 11.86%
1995 8.000.000 26.25%
1996 7.400.000 -8.11%
1997 6.800.000 -8.82%
1998 5.600.000 -21.43%
1999 5.800.000 3.45%
2000 7.034.000 17.54%
2001 8.140.000 13.59%
2002 9.218.000 11.69%
2003 10.054.000 8.32%
2004 9.257.000 -8.61%
2005 9.724.000 4.8%
2006 12.825.000 24.18%
2007 18.510.000 30.71%
2008 20.353.000 9.06%
2009 8.651.000 -135.27%
2010 9.469.000 8.64%
2011 10.602.000 10.69%
2012 10.406.000 -1.88%
2013 12.277.000 15.24%
2014 21.461.000 42.79%
2015 21.896.000 1.99%
2016 27.526.000 20.45%
2017 27.729.000 0.73%
2018 27.690.000 -0.14%
2019 36.505.000 24.15%
2020 43.788.000 16.63%
2021 41.735.000 -4.92%
2022 55.665.000 25.02%
2023 43.216.000 -28.81%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Balchem Corporation EBITDA
Year EBITDA Growth
1985 500.000
1986 800.000 37.5%
1987 900.000 11.11%
1988 1.100.000 18.18%
1989 1.000.000 -10%
1990 1.600.000 37.5%
1991 1.800.000 11.11%
1992 1.500.000 -20%
1993 1.700.000 11.76%
1994 2.200.000 22.73%
1995 3.500.000 37.14%
1996 4.600.000 23.91%
1997 5.400.000 14.81%
1998 6.500.000 16.92%
1999 7.000.000 7.14%
2000 9.968.000 29.78%
2001 10.285.000 3.08%
2002 15.095.000 31.86%
2003 12.540.000 -20.37%
2004 16.056.000 21.9%
2005 775.630.000 97.93%
2006 22.607.000 -3330.93%
2007 31.963.000 29.27%
2008 37.195.000 14.07%
2009 40.716.000 8.65%
2010 58.618.000 30.54%
2011 65.700.000 10.78%
2012 69.418.000 5.36%
2013 76.316.000 9.04%
2014 112.667.000 32.26%
2015 133.620.000 15.68%
2016 137.040.000 2.5%
2017 141.634.000 3.24%
2018 152.417.000 7.07%
2019 148.415.000 -2.7%
2020 162.428.000 8.63%
2021 176.381.000 7.91%
2022 197.034.000 10.48%
2023 174.456.000 -12.94%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Balchem Corporation Gross Profit
Year Gross Profit Growth
1985 2.500.000
1986 2.900.000 13.79%
1987 3.400.000 14.71%
1988 4.000.000 15%
1989 4.100.000 2.44%
1990 5.200.000 21.15%
1991 6.100.000 14.75%
1992 6.100.000 0%
1993 6.800.000 10.29%
1994 8.700.000 21.84%
1995 12.300.000 29.27%
1996 12.700.000 3.15%
1997 13.300.000 4.51%
1998 13.100.000 -1.53%
1999 14.100.000 7.09%
2000 16.056.000 12.18%
2001 17.926.000 10.43%
2002 23.310.000 23.1%
2003 21.152.000 -10.2%
2004 23.806.000 11.15%
2005 784.680.000 96.97%
2006 34.006.000 -2207.48%
2007 46.930.000 27.54%
2008 52.578.000 10.74%
2009 66.958.000 21.48%
2010 78.037.000 14.2%
2011 86.001.000 9.26%
2012 89.539.000 3.95%
2013 97.421.000 8.09%
2014 144.172.000 32.43%
2015 168.097.000 14.23%
2016 180.861.000 7.06%
2017 189.009.000 4.31%
2018 204.252.000 7.46%
2019 211.367.000 3.37%
2020 223.897.000 5.6%
2021 243.174.000 7.93%
2022 280.451.000 13.29%
2023 306.176.000 8.4%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Balchem Corporation Net Profit
Year Net Profit Growth
1985 400.000
1986 300.000 -33.33%
1987 400.000 25%
1988 400.000 0%
1989 300.000 -33.33%
1990 600.000 50%
1991 800.000 25%
1992 200.000 -300%
1993 600.000 66.67%
1994 800.000 25%
1995 1.600.000 50%
1996 1.900.000 15.79%
1997 2.800.000 32.14%
1998 3.000.000 6.67%
1999 3.100.000 3.23%
2000 3.729.000 16.87%
2001 5.110.000 27.03%
2002 7.416.000 31.09%
2003 5.638.000 -31.54%
2004 8.026.000 29.75%
2005 10.954.000 26.73%
2006 12.278.000 10.78%
2007 16.118.000 23.82%
2008 19.050.000 15.39%
2009 26.785.000 28.88%
2010 33.277.000 19.51%
2011 38.765.000 14.16%
2012 40.005.000 3.1%
2013 44.874.000 10.85%
2014 52.826.000 15.05%
2015 59.722.000 11.55%
2016 55.972.000 -6.7%
2017 90.071.000 37.86%
2018 78.573.000 -14.63%
2019 79.671.000 1.38%
2020 84.623.000 5.85%
2021 96.104.000 11.95%
2022 105.367.000 8.79%
2023 116.300.000 9.4%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Balchem Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 1 0%
2008 1 0%
2009 1 0%
2010 1 100%
2011 1 0%
2012 1 0%
2013 2 0%
2014 2 0%
2015 2 0%
2016 2 0%
2017 3 50%
2018 2 0%
2019 2 0%
2020 3 0%
2021 3 0%
2022 3 33.33%
2023 4 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Balchem Corporation Free Cashflow
Year Free Cashflow Growth
1989 400.000
1990 400.000 0%
1991 -300.000 233.33%
1992 -100.000 -200%
1993 -800.000 87.5%
1994 -900.000 11.11%
1995 500.000 280%
1996 2.600.000 80.77%
1997 1.900.000 -36.84%
1998 2.300.000 17.39%
1999 4.100.000 43.9%
2000 5.072.000 19.16%
2001 1.272.000 -298.74%
2002 94.000 -1253.19%
2003 8.883.000 98.94%
2004 10.930.000 18.73%
2005 11.929.000 8.37%
2006 14.010.000 14.85%
2007 10.596.000 -32.22%
2008 17.635.000 39.91%
2009 44.428.000 60.31%
2010 31.473.000 -41.16%
2011 38.265.000 17.75%
2012 39.777.000 3.8%
2013 47.275.000 15.86%
2014 71.983.000 34.32%
2015 61.515.000 -17.02%
2016 83.619.000 26.43%
2017 82.523.000 -1.33%
2018 98.974.000 16.62%
2019 96.048.000 -3.05%
2020 116.666.000 17.67%
2021 123.065.000 5.2%
2022 88.246.000 -39.46%
2023 38.161.000 -131.25%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Balchem Corporation Operating Cashflow
Year Operating Cashflow Growth
1989 1.000.000
1990 1.000.000 0%
1991 1.200.000 16.67%
1992 600.000 -100%
1993 500.000 -20%
1994 1.900.000 73.68%
1995 1.600.000 -18.75%
1996 3.600.000 55.56%
1997 3.000.000 -20%
1998 3.900.000 23.08%
1999 4.700.000 17.02%
2000 5.953.000 21.05%
2001 3.222.000 -84.76%
2002 10.114.000 68.14%
2003 11.153.000 9.32%
2004 12.145.000 8.17%
2005 13.698.000 11.34%
2006 16.370.000 16.32%
2007 15.637.000 -4.69%
2008 22.897.000 31.71%
2009 48.072.000 52.37%
2010 39.030.000 -23.17%
2011 44.902.000 13.08%
2012 53.781.000 16.51%
2013 55.692.000 3.43%
2014 85.350.000 34.75%
2015 103.826.000 17.8%
2016 107.612.000 3.52%
2017 110.618.000 2.72%
2018 118.697.000 6.81%
2019 124.461.000 4.63%
2020 150.494.000 17.3%
2021 160.514.000 6.24%
2022 138.536.000 -15.86%
2023 46.526.000 -197.76%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Balchem Corporation Capital Expenditure
Year Capital Expenditure Growth
1989 600.000
1990 600.000 0%
1991 1.500.000 60%
1992 700.000 -114.29%
1993 1.300.000 46.15%
1994 2.800.000 53.57%
1995 1.100.000 -154.55%
1996 1.000.000 -10%
1997 1.100.000 9.09%
1998 1.600.000 31.25%
1999 600.000 -166.67%
2000 881.000 31.9%
2001 1.950.000 54.82%
2002 10.020.000 80.54%
2003 2.270.000 -341.41%
2004 1.215.000 -86.83%
2005 1.769.000 31.32%
2006 2.360.000 25.04%
2007 5.041.000 53.18%
2008 5.262.000 4.2%
2009 3.644.000 -44.4%
2010 7.557.000 51.78%
2011 6.637.000 -13.86%
2012 14.004.000 52.61%
2013 8.417.000 -66.38%
2014 13.367.000 37.03%
2015 42.311.000 68.41%
2016 23.993.000 -76.35%
2017 28.095.000 14.6%
2018 19.723.000 -42.45%
2019 28.413.000 30.58%
2020 33.828.000 16.01%
2021 37.449.000 9.67%
2022 50.290.000 25.53%
2023 8.365.000 -501.2%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Balchem Corporation Equity
Year Equity Growth
1985 1.800.000
1986 2.100.000 14.29%
1987 2.400.000 12.5%
1988 2.800.000 14.29%
1989 3.100.000 9.68%
1990 3.700.000 16.22%
1991 4.400.000 15.91%
1992 4.500.000 2.22%
1993 5.100.000 11.76%
1994 5.900.000 13.56%
1995 7.400.000 20.27%
1996 9.400.000 21.28%
1997 12.300.000 23.58%
1998 15.800.000 22.15%
1999 17.900.000 11.73%
2000 19.580.000 8.58%
2001 25.332.000 22.71%
2002 33.269.000 23.86%
2003 39.781.000 16.37%
2004 50.234.000 20.81%
2005 60.933.000 17.56%
2006 75.362.000 19.15%
2007 93.080.000 19.04%
2008 114.506.000 18.71%
2009 147.143.000 22.18%
2010 187.467.000 21.51%
2011 232.009.000 19.2%
2012 273.012.000 15.02%
2013 331.358.000 17.61%
2014 391.898.000 15.45%
2015 463.705.000 15.49%
2016 521.033.000 11%
2017 616.881.000 15.54%
2018 691.618.000 10.81%
2019 743.667.000 7%
2020 828.233.000 10.21%
2021 877.015.000 5.56%
2022 938.284.000 6.53%
2023 1.025.267.000 8.48%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Balchem Corporation Assets
Year Assets Growth
1985 3.600.000
1986 3.800.000 5.26%
1987 4.800.000 20.83%
1988 5.800.000 17.24%
1989 5.500.000 -5.45%
1990 6.000.000 8.33%
1991 7.600.000 21.05%
1992 7.600.000 0%
1993 9.200.000 17.39%
1994 12.300.000 25.2%
1995 14.300.000 13.99%
1996 15.100.000 5.3%
1997 17.600.000 14.2%
1998 22.600.000 22.12%
1999 22.000.000 -2.73%
2000 23.222.000 5.26%
2001 44.477.000 47.79%
2002 53.298.000 16.55%
2003 56.906.000 6.34%
2004 60.405.000 5.79%
2005 75.141.000 19.61%
2006 92.333.000 18.62%
2007 154.424.000 40.21%
2008 154.474.000 0.03%
2009 187.813.000 17.75%
2010 228.624.000 17.85%
2011 271.717.000 15.86%
2012 312.545.000 13.06%
2013 376.872.000 17.07%
2014 861.271.000 56.24%
2015 881.223.000 2.26%
2016 948.626.000 7.11%
2017 963.636.000 1.56%
2018 981.355.000 1.81%
2019 1.155.682.000 15.08%
2020 1.165.843.000 0.87%
2021 1.199.325.000 2.79%
2022 1.624.512.000 26.17%
2023 1.603.484.000 -1.31%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Balchem Corporation Liabilities
Year Liabilities Growth
1985 1.800.000
1986 1.700.000 -5.88%
1987 2.400.000 29.17%
1988 3.000.000 20%
1989 2.400.000 -25%
1990 2.300.000 -4.35%
1991 3.200.000 28.13%
1992 3.100.000 -3.23%
1993 4.100.000 24.39%
1994 6.400.000 35.94%
1995 6.900.000 7.25%
1996 5.700.000 -21.05%
1997 5.300.000 -7.55%
1998 6.800.000 22.06%
1999 4.100.000 -65.85%
2000 3.642.000 -12.58%
2001 19.145.000 80.98%
2002 20.029.000 4.41%
2003 17.125.000 -16.96%
2004 10.171.000 -68.37%
2005 14.208.000 28.41%
2006 16.971.000 16.28%
2007 61.344.000 72.33%
2008 39.968.000 -53.48%
2009 40.670.000 1.73%
2010 41.157.000 1.18%
2011 39.708.000 -3.65%
2012 39.533.000 -0.44%
2013 45.514.000 13.14%
2014 469.373.000 90.3%
2015 417.518.000 -12.42%
2016 427.593.000 2.36%
2017 346.755.000 -23.31%
2018 289.737.000 -19.68%
2019 412.015.000 29.68%
2020 337.610.000 -22.04%
2021 322.310.000 -4.75%
2022 686.228.000 53.03%
2023 578.217.000 -18.68%

Balchem Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
28.84
Net Income per Share
3.22
Price to Earning Ratio
44.06x
Price To Sales Ratio
4.93x
POCF Ratio
28.81
PFCF Ratio
38.99
Price to Book Ratio
4.44
EV to Sales
5.26
EV Over EBITDA
26.89
EV to Operating CashFlow
30.84
EV to FreeCashFlow
41.58
Earnings Yield
0.02
FreeCashFlow Yield
0.03
Market Cap
4,57 Bil.
Enterprise Value
4,87 Bil.
Graham Number
48.07
Graham NetNet
-10.78

Income Statement Metrics

Net Income per Share
3.22
Income Quality
1.53
ROE
0.1
Return On Assets
0.07
Return On Capital Employed
0.12
Net Income per EBT
0.79
EBT Per Ebit
0.76
Ebit per Revenue
0.2
Effective Tax Rate
0.21

Margins

Sales, General, & Administrative to Revenue
0.06
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0.02
Gross Profit Margin
0.33
Operating Profit Margin
0.2
Pretax Profit Margin
0.15
Net Profit Margin
0.12

Dividends

Dividend Yield
0.01
Dividend Yield %
0.56
Payout Ratio
0.22
Dividend Per Share
0.79

Operating Metrics

Operating Cashflow per Share
4.92
Free CashFlow per Share
3.65
Capex to Operating CashFlow
-0.26
Capex to Revenue
-0.04
Capex to Depreciation
-0.75
Return on Invested Capital
0.08
Return on Tangible Assets
0.16
Days Sales Outstanding
50.84
Days Payables Outstanding
28.77
Days of Inventory on Hand
67.35
Receivables Turnover
7.18
Payables Turnover
12.69
Inventory Turnover
5.42
Capex per Share
-1.27

Balance Sheet

Cash per Share
2,40
Book Value per Share
31,92
Tangible Book Value per Share
2.07
Shareholders Equity per Share
31.92
Interest Debt per Share
12.67
Debt to Equity
0.37
Debt to Assets
0.24
Net Debt to EBITDA
1.68
Current Ratio
3.16
Tangible Asset Value
0,07 Bil.
Net Current Asset Value
-0,24 Bil.
Invested Capital
0.37
Working Capital
0,23 Bil.
Intangibles to Total Assets
0.6
Average Receivables
0,13 Bil.
Average Payables
0,05 Bil.
Average Inventory
120647500
Debt to Market Cap
0.08

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Balchem Corporation Dividends
Year Dividends Growth
1988 0
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 1 0%
2020 1 0%
2021 1 0%
2022 1 0%
2023 0 0%

Balchem Corporation Profile

About Balchem Corporation

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.

CEO
Mr. Theodore L. Harris
Employee
1.302
Address
52 Sunrise Park Road
New Hampton, 10958

Balchem Corporation Executives & BODs

Balchem Corporation Executives & BODs
# Name Age
1 Mr. M. Brent Tignor
Senior Vice President & Chief Human Resources Officer
70
2 Mr. William A. Backus CPA
Vice President & Chief Accounting Officer
70
3 Ms. Hatsuki Miyata
Executive Vice President, General Counsel & Secretary
70
4 Mr. Michael R. Sestrick Ph.D.
Senior Vice President & Chief Technology Officer
70
5 Mr. Job L. van Gunsteren
Senior Vice President & GM of Specialty Products
70
6 Mr. Theodore L. Harris
Chairman, Chief Executive Officer & President
70
7 Mr. Frederic Boned
Senior Vice President and GM of Human Nutrition & Health
70
8 Mr. Carl Martin Bengtsson
Executive Vice President, Chief Financial Officer & Treasurer
70
9 Mr. Jonathan H. Griffin
Senior Vice President and GM of Animal Nutrition & Health
70
10 Mr. Martin Luther Reid
Senior Vice President & Chief Supply Chain Officer
70

Balchem Corporation Competitors